Technical Analysis for HOWL - Werewolf Therapeutics, Inc.

Grade Last Price % Change Price Change
C 5.84 4.10% 0.23
HOWL closed up 4.1 percent on Wednesday, April 17, 2024, on 2.01 times normal volume.
Earnings due: May 8
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
20 DMA Resistance Bearish 4.10%
Pocket Pivot Bullish Swing Setup 4.10%
Lower Bollinger Band Walk Weakness 4.10%
Wide Bands Range Expansion 4.10%
Slingshot Bearish Bearish Swing Setup 6.38%
Lower Bollinger Band Walk Weakness 6.38%
Wide Bands Range Expansion 6.38%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 16 hours ago
Up 5% about 16 hours ago
Rose Above 20 DMA about 16 hours ago
Rose Above Previous Day's High about 16 hours ago
5x Volume Pace about 16 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Werewolf Therapeutics, Inc. Description

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It offers PREDATOR, a platform of protein engineering technology to design and engineer the future of immuno-oncology biotherapeutics for patients. The company's lead product candidates include WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. It also develops WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Solid Tumors Health Sciences Treatment Of Cancer Cancer Immunotherapy Lymphoma Hematologic Malignancies Advanced Solid Tumors Metastatic Solid Tumors

Is HOWL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.1939
52 Week Low 1.5735
Average Volume 203,517
200-Day Moving Average 3.82
50-Day Moving Average 6.28
20-Day Moving Average 5.80
10-Day Moving Average 5.46
Average True Range 0.48
RSI (14) 50.25
ADX 18.08
+DI 21.88
-DI 23.31
Chandelier Exit (Long, 3 ATRs) 5.31
Chandelier Exit (Short, 3 ATRs) 5.93
Upper Bollinger Bands 6.71
Lower Bollinger Band 4.90
Percent B (%b) 0.52
BandWidth 31.17
MACD Line -0.22
MACD Signal Line -0.20
MACD Histogram -0.0148
Fundamentals Value
Market Cap 211.36 Million
Num Shares 36.2 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -5.31
Price-to-Sales 8.61
Price-to-Book 2.22
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.58
Resistance 3 (R3) 6.56 6.30 6.45
Resistance 2 (R2) 6.30 6.11 6.31 6.41
Resistance 1 (R1) 6.07 6.00 6.19 6.09 6.37
Pivot Point 5.81 5.81 5.87 5.82 5.81
Support 1 (S1) 5.58 5.62 5.70 5.60 5.31
Support 2 (S2) 5.32 5.51 5.33 5.27
Support 3 (S3) 5.09 5.32 5.23
Support 4 (S4) 5.11